Related Experiment Video
Updated: Jun 26, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation
Xiaofeng Ding1, Chang Luo, Jianlin Zhou
1Model Animal Research Center, Nanjing University, Nanjing 210089, PR China.
Abstract:
AP-2 is a transcription factor implicated in mammalian development, cell proliferation, apoptosis, and carcinogenesis. To identify potential AP-2alpha-interacting partners, a yeast two-hybrid screen was performed in human brain cDNA library. One of the identified clones encodes potassium channel tetramerization domain-containing 1 (KCTD1). We demonstrated the novel KCTD1-AP-2alpha interaction in vitro by GST pull-down assays and in vivo by co-immunoprecipitation assays and mapped the interaction domains to the N-termini of both proteins. In addition, we observed that the two proteins were completely co-localized in the nuclei of mammalian cells. Transient transfection assays using four promoters containing AP-2-binding sites confirmed that KCTD1 significantly repressed AP-2alpha-mediated transactivation through the BTB domain, whereas KCTD1 siRNA strongly relieved KCTD1-mediated repression of AP-2alpha transcriptional activity, and other BTB domain proteins such as PDIP1, KCTD10, and TNFAIP1 did not markedly inhibit the transcriptional activity of AP-2alpha, suggesting that KCTD1 specifically acts as a negative regulator of AP-2alpha. Finally, we found that KCTD1 interacted with three major members of the AP-2 family and inhibited their transcriptional activities. Taken together, our results indicate the novel function of KCTD1 as the transcriptional repressor for AP-2 family, especially for AP-2alpha.
Insights
Potassium channel tetramerization domain-containing 1 (KCTD1) interacts with the AP-2 transcription factor. KCTD1 specifically represses AP-2alpha
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Transcription factor AP-2 (Activating Protein-2) is crucial for mammalian development, cell proliferation, apoptosis, and carcinogenesis.
- Identifying AP-2 interacting partners is key to understanding its regulatory mechanisms.
Purpose of the Study:
- To identify novel AP-2alpha interacting proteins.
- To characterize the functional interaction between KCTD1 and AP-2alpha.
Main Methods:
- Yeast two-hybrid screen using a human brain cDNA library.
- In vitro GST pull-down and in vivo co-immunoprecipitation assays.
- Mammalian cell co-localization studies and transient transfection assays with AP-2-binding site promoters.
- siRNA-mediated knockdown of KCTD1.
Main Results:
- KCTD1 was identified as an AP-2alpha interacting partner.
- The interaction was confirmed in vitro and in vivo, with binding domains mapped to the N-termini of both proteins.
- KCTD1 specifically repressed AP-2alpha-mediated transactivation, and this repression was relieved by KCTD1 siRNA.
- KCTD1 also inhibited the transcriptional activity of other AP-2 family members.
Conclusions:
- KCTD1 functions as a novel transcriptional repressor for the AP-2 family, particularly AP-2alpha.
- This interaction provides new insights into the regulation of AP-2 transcriptional activity.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Anaphase Promoting Complex
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
